Trial Profile
A phase I study to assess the safety and immunogenicity of new TB vaccine candidates FP85A and MVA85A, in healthy adults who have previously been immunized with BCG, using a prime-boost delivery schedule
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2012
Price :
$35
*
At a glance
- Drugs MVA 85A (Primary) ; Tuberculosis vaccine
- Indications Tuberculosis
- Focus Adverse reactions
- 01 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 19 Dec 2009 'The Welcome Trust' added as trial sponsor as reported by ISRCTN: Current Controlled Trials.
- 19 Dec 2009 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ISRCTN: Current Controlled Trials.